|
SPTLC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.43218770176645E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.00589997337397E-10 |
| Normal-vs-Stage2 |
8.07630000000392E-05 |
| Normal-vs-Stage3 |
5.21804821573824E-15 |
| Normal-vs-Stage4 |
2.23099316798425E-12 |
| Stage1-vs-Stage2 |
8.515800E-01 |
| Stage1-vs-Stage3 |
1.72918999999938E-05 |
| Stage1-vs-Stage4 |
1.838910E-04 |
| Stage2-vs-Stage3 |
3.234200E-02 |
| Stage2-vs-Stage4 |
4.427800E-02 |
| Stage3-vs-Stage4 |
9.328200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.73927539037777E-12 |
| Normal-vs-AfricanAmerican |
5.39320033077217E-10 |
| Normal-vs-Asian |
1.672800E-01 |
| Caucasian-vs-AfricanAmerican |
4.243000E-01 |
| Caucasian-vs-Asian |
2.320800E-01 |
| AfricanAmerican-vs-Asian |
8.351800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.89848137210902E-14 |
| Normal-vs-Female |
2.941700216752E-10 |
| Male-vs-Female |
9.592500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.12309999999549E-05 |
| Normal-vs-Age(41-60Yrs) |
6.56789955755244E-10 |
| Normal-vs-Age(61-80Yrs) |
1.62891922173003E-12 |
| Normal-vs-Age(81-100Yrs) |
1.64886999999281E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.025400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.444000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.852600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.152000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.405000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.713000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.265570E-01 |
| Normal-vs-Grade 2 |
6.59380000045395E-07 |
| Normal-vs-Grade 3 |
1.79933845600999E-12 |
| Normal-vs-Grade 4 |
1.63080660087189E-12 |
| Grade 1-vs-Grade 2 |
3.943400E-01 |
| Grade 1-vs-Grade 3 |
2.297900E-03 |
| Grade 1-vs-Grade 4 |
7.555500E-04 |
| Grade 2-vs-Grade 3 |
7.85679999948385E-07 |
| Grade 2-vs-Grade 4 |
2.08350000030499E-07 |
| Grade 3-vs-Grade 4 |
1.596480E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.98539999995972E-06 |
| Normal-vs-ccB subtype |
1.64035451888367E-12 |
| ccA subtype-vs-ccB subtype |
2.33350000000687E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.06039954594905E-10 |
| Normal-vs-N1 |
5.52549999999208E-05 |
| N0-vs-N1 |
2.524600E-01 |
|
|
